Tag: Technology

FDA announces Class 1 recall for ventilator adapter assemblies

Editor's Note The US Food and Drug Administration (FDA) designated Baxter’s recall of certain Single Patient Use Circuits and Blue Ventilator Adapter Assemblies as Class 1, the most severe recall category indicating significant risk of injury or death. The Single Patient Use Circuit and Blue Adapter Assembly are patient circuit…

Read More

By: Matt Danford
September 5, 2024
Share

HHS withdraws appeal on rule limiting hospital use of web tracking technology

Editor's Note The US Department of Health and Human Services (HHS) has withdrawn its appeal against a federal court decision that blocked a rule restricting hospitals from using tracking technology on their websites, HealthLeaders August 30 reports. This rule, proposed in December 2022 by the HHS Office for Civil Rights,…

Read More

By: Tarsilla Moura
September 3, 2024
Share

Water quality: 5 Ws and an H for sterile processing pros

Asking who, what, why, when, where, and how—otherwise known as the “5 Ws and an H”— is a time-tested way for writers and researchers to ensure comprehensive coverage of any topic. Here, we apply this framework from the perspective of sterile processing department (SPD) professionals seeking to start a water…

Read More

By: Angela Lewellyn, LPN, CRCST, CER, CHL
August 28, 2024
Share

Staffing solutions depend on collaborative, innovative culture

There is no shortage of advice, opinions, and proposed solutions when it comes to staff shortages, but the issue continues to plague healthcare systems nonetheless. For a couple of years now, speakers at the OR Business Management Conference and OR Manager Conference have been asking attendees, “Who still struggles to…

Read More

By: Tarsilla Moura
August 28, 2024
Share

Pilot project takeoff proves promise of AI staff optimization

Perioperative leaders face mounting pressures to optimize resources, reduce costs, and improve patient outcomes. However, one challenge stands out among the rest: OR staffing shortages. According to a November/December survey conducted by LeanTaaS in collaboration with OR Manager, staff recruitment and retention is a top priority for OR leaders this…

Read More

By: Stacey Leadbeater
August 28, 2024
Share

FDA announces Class 1 recall for chest compression devices

Editor's Note The US Food and Drug Administration (FDA) has designated Defibtech, LLC’s recall of RMU-2000 ARM XR Chest Compression Devices as Class 1, the most severe category indicating serious risk of injury or death. A motor issue could stop  compressions in adults whose hearts suddenly stop, according to the…

Read More

By: Matt Danford
August 23, 2024
Share

Studies highlight success strategies for combatting handoff communication failure, care inequity

Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events.   These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…

Read More

By: Matt Danford
August 23, 2024
Share

Immunotherapy’s FDA approval expected to improve lung cancer treatment

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

By: Matt Danford
August 22, 2024
Share

Battery problem prompts FDA Class 1 recall for infusion pumps

Editor's Note The US Food and Drug Adminstration (FDA) has classified a recall of ICU Medical’s Plum 360, Plum A+ and Plum A+3 infusion pumps as Class 1, the most severe category indicating risk of serious injury or death. According to he agency’s August 20 announcement, the company is updating…

Read More

By: Matt Danford
August 21, 2024
Share

Injectable “goo” could eliminate joint surgery, treat osteoarthritis, animal study shows

US news and world report

Editor's Note A newly developed biomaterial could treat crippling arthritis by prompting the growth of new cartilage, according to an animal study conducted at Northwestern University and published in the Proceedings of the National Academy of Sciences. According to an August 6 article by U.S. News and World Report, the…

Read More

By: Matt Danford
August 19, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat